I-3-Cyanoindole CAS 5457-28-3 Ubunyulu ≥98.0% (HPLC) Factory High Quality Featured Image

I-3-Cyanoindole CAS 5457-28-3 Ubunyulu ≥98.0% (HPLC) IFactory High Quality

Inkcazelo emfutshane:

Igama leKhemikhali: 3-Cyanoindole

CAS: 5457-28-3

Ubunyulu: ≥98.0% (HPLC)

Imbonakalo: Mthubi oMthubi ukuya koMthubi wePowder oyikristale

Umgangatho ophezulu, iMveliso yoRhwebo

E-Mail: alvin@ruifuchem.com

Thumela i-imeyile kuthi

Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

I-Shanghai Ruifu Chemical Co., Ltd. ngumenzi ohamba phambili kunye nomthengisi we-3-Cyanoindole (i-CAS: 5457-28-3) enomgangatho ophezulu, imveliso yorhwebo.Wamkelekile kwiodolo.

Iipropati zeMichiza:

Igama leMchiza	3-Cyanoindole
Izithethantonye	1H-Indole-3-Carbonitrile;Indole-3-Carbonitrile;3-Indolecarbonitrile
Inombolo yeCAS	5457-28-3
Inombolo yeCAT	RF-PI1534
Ubume beStokhwe	Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni
Ifomula yeemolekyuli	C9H6N2
Ubunzima beMolekyuli	142.16
Ukunyibilika kwamanzi	Ayinyibilikiyo emanzini
Uphawu	Ruifu Chemical

Iinkcukacha:

Into	Iinkcukacha
Imbonakalo	Umgubo oMthubi oMthubi ukuya koMthubi
Ubunyulu / Indlela yokuHlalutya	≥98.0% (HPLC)
Indawo yokunyibilika	178.0 ~ 181.0℃
Amanzi (KF)	≤0.50%
Ukungcola ngokupheleleyo	≤2.00%
I-1 H NMR Spectrum	Ukungqinelana Nolwakhiwo
Umgangatho woVavanyo	Umgangatho woShishino
Ukusetyenziswa	AbaPhakathi bamayeza

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi.

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma.

Izinto eziluncedo:

FAQ:

Isicelo:

I-3-Cyanoindole (i-CAS: 5457-28-3) i-compound iluncedo kwi-organic synthesis.I-Reactant ukulungiselela: I-Tryptophan dioxygenase inhibitors pyridyl-ethenyl-indoles njenge-anticancer immunomodulators enokubakho;Ii-inhibitors ze-C-terminal domain ye-RNA polymerase II kunye nemisebenzi ye-antitumor I-Biologically active;Indoles Inhibitors ye-glycogen synthase kinase 3β (GSK-3);HIV-1 integrase inhibitors;Amaqhekeza e-Indole njenge-inosine monophosphate dehydrogenase (IMPDH) inhibitors;I-Aziridinomitosene skeleton;Ii-antiviral ezinokwenzeka.